PT-141 and libido: a desire medicine, not a blood-flow pill

How it works

Erectile dysfunction pills such as tadalafil relax blood vessels so blood can flow in when arousal happens. They don't create desire. Bremelanotide works further upstream, activating melanocortin receptors in the brain that are involved in sexual motivation.

That's why it's discussed for low desire rather than for erections alone, and why its side effects, such as nausea and flushing, reflect effects on the nervous system.

What the approved version showed

Vyleesi was tested in two 24-week trials involving 1,247 premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). On a desire scale, women using it improved by about 0.5 to 0.6 points compared with about 0.2 points on placebo, and they also reported less distress about low desire. The number of satisfying sexual events did not differ significantly from placebo.

Nausea was reported by 40% of users, compared with about 1% on placebo, and was most common after the first dose. In the trials, 18% stopped because of side effects, compared with 2% on placebo. The label says to stop if there's no improvement after 8 weeks.

Who it's approved for, and who it isn't

The FDA approval covers premenopausal women whose low desire developed after a period of normal desire, occurs in all situations and causes marked distress, and isn't better explained by a medical or psychiatric condition, relationship problems or a medication. The label states it is not indicated for postmenopausal women, for men or to enhance sexual performance.

Any other use, including in midlife men or after menopause, is off-label, meaning the evidence comes from smaller or less rigorous studies. That doesn't make it inappropriate, but it should be a deliberate, informed choice.

Safety points to know

• It can raise blood pressure and lower heart rate for up to 12 hours after a dose, so it's not used with uncontrolled high blood pressure or known cardiovascular disease.
• No more than one dose in 24 hours, and no more than 8 doses a month, per the approved label.
• Repeated use can darken skin on the face, gums or breasts, sometimes permanently, especially with darker skin tones or daily use.
• It can reduce absorption of oral naltrexone and may interact with some other oral medicines.
• It is not for use during pregnancy.

Desire is often a hormone and life story first

In midlife, low desire frequently has identifiable causes. For women, perimenopause and menopause can bring vaginal dryness and painful sex, poor sleep from night sweats and mood changes, all of which suppress desire. For men, low testosterone, erectile changes and some medicines can play a role.

Antidepressants, blood pressure medicines, stress, relationship strain and fatigue are common contributors for everyone. Addressing these often matters more than adding a desire medicine, and a clinician should look at them first.

Practical expectations

Bremelanotide is taken as needed before sexual activity rather than daily; the approved injection is used at least 45 minutes beforehand. It doesn't create desire on its own in every situation, and context, relationship and mood still matter.

Because nausea is most likely after the first dose, many clinicians suggest a first trial at a calm time, not before an important evening. Keep a simple note of what you noticed each time, including side effects, so your follow-up conversation is based on more than memory. If there's no meaningful change after about 8 weeks, the approved label advises stopping.

How HealifyMD uses PT-141

HealifyMD doesn't offer branded Vyleesi. PT-141 is available as part of the compounded Triple Action Blend, which combines tadalafil, oxytocin and PT-141, listed from $149/month and confirmed at your eligibility review. Compounded PT-141 is not FDA-approved, has not been reviewed by the FDA for safety, effectiveness or quality and isn't equivalent to Vyleesi. Oxytocin's role in sexual function has limited evidence, and tadalafil use in women is off-label.

Your clinician reviews your blood pressure, heart health, medicines and menopausal or testosterone status first. Depending on what's driving low desire, the better option may be hormone therapy, vaginal estrogen, testosterone evaluation, a medication change or single-ingredient treatment.